Cost-effectiveness and budget impact of pembrolizumab+axitinib versus sunitinib in patients with advanced clear-cell renal cell carcinoma in the Netherlands von Xander, Nicolas S H, Fiets, W Edward, Uyl-de Groot, Carin A

Volltext

Assessing the clinical benefit of systemic anti-cancer treatments in the Netherlands: The impact of different thresholds for effectiveness von Leeneman, Brenda, Xander, Nicolas S.H., Fiets, W. Edward, de Jong, Wouter K., Uyl, Nathalie E.M., Wymenga, A.N. Machteld, Reyners, An K.L., Uyl-de Groot, Carin A.

Volltext

Methotrexate plus or minus cetuximab as first‐line treatment in a recurrent or metastatic (R/M) squamous cell carcinoma population of the head and neck (SCCHN), unfit for cisplatin... von Ham, Janneke C., Meerten, Esther, Fiets, W. Edward, Beerepoot, Laurens V., Jeurissen, Frank J. F., Slingerland, Marije, Jonker, Marianne A., Husson, Olga, Graaf, Winette T. A., Herpen, Carla M. L.

Volltext

Pooled analysis of prognostic impact of uPA and PAI-1 in breast cancer patients von Look, Maxime, van Putten, Wim, Duffy, Michael, Harbeck, Nadia, Jarle Christensen, Ib, Thomssen, Christoph, Kates, Ronald, Spyratos, Frédérique, Fernö, Mårten, Eppenberger-Castori, Serenella, Fred Sweep, C. G. J., Ulm, Kurt, Peyrat, Jean-Philippe, Martin, Pierre-Marie, Magdelenat, Henri, Brünner, Nils, Duggan, Catherine, Lisboa, Björn W., Bendahl, Pär-Ola, Quillien, Véronique, Daver, Alain, Ricolleau, Gabriel, Meijer-van Gelder, Marion, Manders, Peggy, Fiets, Edward W., Blankenstein, Marinus, Broët, Philippe, Romain, Sylvie, Daxenbichler, Günther, Windbichler, Gudrun, Cufer, Tanja, Borstnar, Simona, Kueng, Willy, Beex, Louk, Klijn, Jan, O’Higgins, Nial, Eppenberger, Urs, Jänicke, Fritz, Schmitt, Manfred, Foekens, John

Volltext

Assessing the clinical benefit of systemic anti-cancer treatments in the Netherlands: The impact of different thresholds for effectiveness von Leeneman, Brenda, Xander, Nicolas S.H, Fiets, W. Edward, de Jong, Wouter K, Uyl, Nathalie E.M, Wymenga, A. N.Machteld, Reyners, An K.L, Uyl-de Groot, Carin A

Volltext

TGF-β and PD-L1 inhibition combined with definitive chemoradiotherapy in esophageal squamous cell carcinoma: A phase II clinical trial (NCT04595149) von Veen, Linde, Hulshof, Maarten C.C.M., Jimenez, Connie R., Cuppen, Edwin P.J.G., Beerepoot, Laurens V., Creemers, Geert-Jan, Fiets, W. Edward, Jeene, Paul M., Lipman, Djoeri, Haj Mohammad, Nadia, Oppedijk, Vera, Slingerland, Marije, Vervenne, Walter L., Bijlsma, Maarten F., Van Laarhoven, Hanneke W.M.

Volltext

796. P02.05 NEOADJUVANT CHEMORADIOTHERAPY FOLLOWED BY ACTIVE SURVEILLANCE VERSUS STANDARD SURGERY FOR OESOPHAGEAL CANCER (SANO-TRIAL): A MULTICENTRE STEPPED-WEDGE CLUSTER-RANDOMISE... von Van Der Wilk, Berend, Eyck, Ben M, Wijnhoven, Bas PL, Lagarde, Sjoerd M, Rosman, Camiel, Noordman, Bo J, Valkema, Maria J, Bisseling, Tanya M, Coene, Peter-Paul LO, van Det, Marc J, Dekker, Jan-Willem T, van Dieren, Jolanda M, Doukas, Michail, van Esser, Stijn, Fiets, W Edward, Hartgrink, Henk H, Heisterkamp, Joos, Holster, I Lisanne, Klarenbeek, Bastiaan, van Klaveren, David, Kouw, Eva, Kouwenhoven, Ewout A, Luyer, Misha D, Mostert, Bianca, Nieuwenhuijzen, Grard AP, Oostenbrug, Liekele E, Pierie, Jean-Pierre, van Sandick, Johanna W, Sosef, Meindert N, Spaander, Manon CW, Valkema, Roelf, van der Zaag, Edwin S, Steyerberg, Ewout W, van Lanschot, J Jan B

Volltext

Cost-effectiveness of prophylactic antibiotics to prevent pneumonia in patients treated with chemoradiotherapy (CRT) for locally advanced head and neck carcinoma (LAHNC) von Ham, Janneke, Driessen, Chantal, Hendriks, Mathijs P, Fiets, W. Edward, Kreike, Bas, Hoeben, Ann, Slingerland, Marije, Opstal, Claudia van, Kullberg, Bart-Jan, Adang, Eddy MM, Kaanders, Johannes, Van Der Graaf, Winette T.A., Van Herpen, Carla M.L.-

Volltext

Prophylactic antibiotics to prevent pneumonia in patients treated with chemoradiotherapy (CRT) for locally advanced head and neck carcinoma (LAHNC) von Ham, Janneke, Driessen, Chantal, Hendriks, Mathijs P, Fiets, W. Edward, Kreike, Bas, Hoeben, Ann, Slingerland, Marije, Opstal, Claudia van, Kullberg, Bart-Jan, Peer, Petronella, Kaanders, Johannes, van der Graaf, Winette TA, Van Herpen, Carla M.L.

Volltext

Pooled Analysis of Prognostic Impact of Urokinase-Type Plasminogen Activator and Its Inhibitor PAI-1 in 8377 Breast Cancer Patients von Look, Maxime P., van Putten, Wim L. J., Duffy, Michael J., Harbeck, Nadia, Christensen, Ib Jarle, Thomssen, Christoph, Kates, Ronald, Spyratos, Frédérique, Fernö, Mårten, Eppenberger-Castori, Serenella, Sweep, C. G. J. Fred, Ulm, Kurt, Peyrat, Jean-Philippe, Martin, Pierre-Marie, Magdelenat, Henri, Brünner, Nils, Duggan, Catherine, Lisboa, Björn W., Bendahl, Pär-Ola, Quillien, Véronique, Daver, Alain, Ricolleau, Gabriel, Meijer-van Gelder, Marion E., Manders, Peggy, Fiets, W. Edward, Blankenstein, Marinus A., Broët, Philippe, Romain, Sylvie, Daxenbichler, Günter, Windbichler, Gudrun, Cufer, Tanja, Borstnar, Simona, Kueng, Willy, Beex, Louk V. A. M., Klijn, Jan G. M., O'Higgins, Niall, Eppenberger, Urs, Jänicke, Fritz, Schmitt, Manfred, Foekens, John A.

Volltext

Mannose-binding lectin (MBL) serum level and genotype and risk of chemotherapy-induced febrile neutropenia (FN) in patients with solid tumors von Goudzwaard, J., Fiets, W. Edward, van de Geijn, G.J., Njo, T., Zuetenhorst, J.M, Birnie, E., van Schaik, R. H.N., Putten, M. van der, Polee, Marco, Hamberg, Paul

Volltext

Serum lactate dehydrogenase (LDH) as a prognostic selection criterion for ipilimumab treatment in metastatic melanoma von Blank, Christian U., Kelderman, Sander, van Tinteren, Harm, Heemskerk, Bianca, van den Brom, Rob, Hospers, Geke A., van den Eertwegh, Alfons JM, Kapiteijn, Ellen, De Groot, Jan Willem, Jansen, Rob L., Fiets, W. Edward, Krzystanek, Marcin, Szallasi, Zoltan, Furness, Andrew James Scott, Renn, Alex, Gore, Martin Eric, Lorigan, Paul, Schumacher, Ton, Haanen, John B. A. G., Larkin, James M. G.

Volltext

Pooled analysis of prognostic impact of uPA and PAI-I in breast cancer patients von LOOK, Maxime, VAN PUTTEN, Wim, SWEEP, C. G. J. Fred, ULM, Kurt, PEYRAT, Jean-Philippe, MARTIN, Pierre-Marie, MAGDELENAT, Henri, BRÜNNER, Nils, DUGGAN, Catherine, LISBOA, Björn W, BENDAH, Pär-Ola, QUILLIEN, Véronique, DUFFY, Michael, DAVER, Alain, RICOLLEAU, Gabriel, MEIJER-VAN GELDER, Marion, MANDERS, Peggy, FIETS, W. Edward, BLANKENSTEIN, Marinus, BROËT, Philippe, ROMAIN, Sylvie, DAXENBICHLER, Günther, WINDBICHLER, Gudrun, HARBECK, Nadia, CUFER, Tanja, BORSTNAR, Simona, KUENG, Willy, BEEX, Louk, KLIJN, Jan, O'HIGGINS, Nial, EPPENBERGER, Urs, JÄNICKE, Fritz, SCHMITT, Manfred, FOEKENS, John, CHRISTENSEN, Ib Jarle, THOMSSEN, Christoph, KATES, Ronald, SPYRATOS, Frédérique, FERNÖ, Marten, EPPENBERGER-CASTORI, Serenella

Volltext

Lactate dehydrogenase as a selection criterion for ipilimumab treatment in metastatic melanoma von Kelderman, Sander, Heemskerk, Bianca, van Tinteren, Harm, van den Brom, Rob R. H., Hospers, Geke A. P., van den Eertwegh, Alfonsus J. M., Kapiteijn, Ellen W., de Groot, Jan Willem B., Soetekouw, Patricia, Jansen, Rob L., Fiets, Edward, Furness, Andrew J. S., Renn, Alexandra, Krzystanek, Marcin, Szallasi, Zoltan, Lorigan, Paul, Gore, Martin E., Schumacher, Ton N. M., Haanen, John B. A. G., Larkin, James M. G., Blank, Christian U.

Volltext